Tofacitinib Receives FDA Approval for Treatment of Ulcerative Colitis
Tofacitinib is indicated for the treatment of adult patients with severely active ulcerative colitis, severely active rheumatoid arthritis (RA), or psoriatic arthritis (PsA).
Related Articles
FDA Approves Novavax COVID-19 Vaccine for Patients 65 Years and Older, Those With Underlying Conditions
The vaccine, indicated with a restriction on use for those younger than 65 years and without comorbidities, was proven safe and effective in a series…
The Promise of Psilocybin-Assisted Therapy for Opioid Use Disorder
With Oregon, Colorado, and New Mexico legalizing psilocybin-assisted therapy, opportunities for treatment are expanding.
Medication Meltdown: Unpacking Drug Shortages
Pharmacy staff can be instrumental members of shortage management teams.
Interferon Lowers Myelofibrosis Risk in Young Patients With Polycythemia Vera, Essential Thrombocytopenia
Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.
Pharmacist Roles in a Correctional Institution
These pharmacists help bridge gaps for patients in difficult situations.
Pharmacists’ Role in Optimizing Outcomes for Women With Complex Health Needs
Panelists discuss how pharmacists play a crucial role in optimizing health outcomes for women with complex health needs through comprehensive medication management, personalized consultations, and…
New OTC Option Offers Patients Itch Relief During Summer Activities
The seasonal surge in skin irritations underscores the ongoing need for effective and convenient remedies.
Mild to Moderate Adverse Events Possible in Pediatric Patients With Primary Immunodeficiency Receiving IVIG
Despite being an effective treatment option, intravenous immunoglobulin (IVIG) can cause transient adverse events in pediatrics with primary immunodeficiency, including headache and fever.
Children Born to Mothers With Cardiometabolic Issues Before or During Pregnancy Face Increased Risk of Childhood, Adolescent Hypertension
Maternal cardiometabolic issues during pregnancy significantly elevate children’s blood pressure, highlighting the need for preventive health measures.
Zepbound Shows Superior Weight Loss Compared to Wegovy in SURMOUNT-5 Trial
Tirzepatide outperforms semaglutide in weight loss, achieving an average reduction of 20.2% in a pivotal trial for obesity management.